GHSR

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR

Cat.No.	Product Name	Information	Product Use Citations
S6948	Lanreotide	Lanreotide (Laromustine, Angiopeptin, BIM 23014, Dermopeptin, ITM-014, Lanreotidum), an analog of the native somatostatin peptide, is a physiological inhibitor of growth hormone (GH). This compound also has antitumoral effects.	Cancer Cell, 2025, 43(4):776-796.e14 Cancers (Basel), 2024, 16(17)3104
S4980	Anamorelin	Anamorelin (ONO-7643, RC-1291, ST-1291) is an orally active, high-affinity, selective agonist of the ghrelin receptor with an EC50 value of 0.74 nM in the HEK293/GRLN FLIPR assay.	Drug Test Anal, 2020, 10.1002/dta.2917
E4923	AnaMorelin hydrochloride	Anamorelin hydrochloride(RC-1291 HCL, ONO-7643) is a potent and selective agonist of ghrelin receptor with EC50 of 0.74 nM FLIPR assay. It has a significant appetite-enhancing activity and has the potential to treat cancer anorexia-cachexia syndrome.

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S6948

Lanreotide

Lanreotide (Laromustine, Angiopeptin, BIM 23014, Dermopeptin, ITM-014, Lanreotidum), an analog of the native somatostatin peptide, is a physiological inhibitor of growth hormone (GH). This compound also has antitumoral effects.

Cancer Cell, 2025, 43(4):776-796.e14

Cancers (Basel), 2024, 16(17)3104

S4980

Anamorelin

Anamorelin (ONO-7643, RC-1291, ST-1291) is an orally active, high-affinity, selective agonist of the ghrelin receptor with an EC50 value of 0.74 nM in the HEK293/GRLN FLIPR assay.

Drug Test Anal, 2020, 10.1002/dta.2917

E4923

AnaMorelin hydrochloride

Anamorelin hydrochloride(RC-1291 HCL, ONO-7643) is a potent and selective agonist of ghrelin receptor with EC50 of 0.74 nM FLIPR assay. It has a significant appetite-enhancing activity and has the potential to treat cancer anorexia-cachexia syndrome.